Search Within

Alumni (GSK)

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (91)
  2. Meeting Abstract (42)
  3. Research Letter (2)
  4. Review (2)
  5. Editorial (1)
Groups
  1. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (138)
  2. Molecular Pharmacology and Chemistry Program Faculty (138)
  3. Sloan Kettering Institute Faculty (138)
  4. GSK Faculty (134)
  5. Sloan Kettering Institute Postdocs (124)
  6. Department of Medicine (100)

More Groups

People
  1. Michel Sadelain (29)
  2. Ly Vu (22)
  3. Michael Kharas (22)
  4. Ross Levine (22)
  5. Anton Dobrin (19)
  6. Neal Rosen (18)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (9)
  4. 2022 (13)
  5. 2021 (15)
  6. 2020 (15)

More Years

Publications
  1. Blood (18)
  2. Cancer Research (16)
  3. Nature (9)
  4. Nature Communications (9)
  5. Cancer Discovery (8)
  6. Molecular Therapy (5)

More Publications

Publishers
  1. Nature Publishing Group (41)
  2. American Association for Cancer Research (29)
  3. American Society of Hematology (18)
  4. Cell Press (12)
  5. American Association for the Advancement of Science (4)
  6. American Chemical Society (3)

More Publishers

Results (138)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HLA-independent T cell receptors for targeting tumors with low antigen density
    Journal Article

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A. E.; Li, Z.; Sjöstrand, M.; Lindenbergh, P. L.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Intraperitoneal pretargeted radioimmunotherapy for colorectal peritoneal carcinomatosis
    Journal Article

    Chandler, C. S.; Bell, M. M.; Chung, S. K.; Veach, D. R.; Fung, E. K.; Punzalan, B.; Burnes Vargas, D.; Patel, M.; Xu, H.; Guo, H. F.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • RNA binding protein SYNCRIP is required for the low-output HSC by sustaining proteome quality
    Meeting Abstract

    Herrejon Chavez, F.; Cifani, P.; Pine, A.; Chu, K. L.; Barin, E.; Schurer, A.; Luo, H.; Nguyen, D. T. T.; Kentsis, A.; Leslie, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Sethna, Z.; Luksza, M.; Rojas, L.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • HLA-independent T cell receptors effectively target low abundance antigens
    Meeting Abstract

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A.; Li, Z.; Sjöstrand, M.; Lindenbergh, P.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Rojas, L. A.; Łuksza, M.; Sethna, Z. M.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth
    Journal Article

    Lee, B. J.; Boyer, J. A.; Burnett, G. L.; Thottumkara, A. P.; Tibrewal, N.; Wilson, S. L.; Hsieh, T.; Marquez, A.; Lorenzana, E. G.; Evans, J. W.; more...
    Nature Chemical Biology (2021)

    Fulltext@MSK | Save
  • Emergence of a hyper-proliferative phenotype in TET2 edited human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Iyer, A.; Lopez, M.; Feucht, J.; Koche, R.; Yang, J.; Zhan, Y.; Sadelain, M.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Self-assembling and disassembling bispecific antibody platform for pretargeted radioimmunotherapy against GPA33 in a xenograft model of colorectal peritoneal carcinomatosis
    Meeting Abstract

    Chung, S.; Wang, M.; Veach, D.; Cheal, S.; Burnes Vargas, D.; Seo, S. H.; Punzalan, B.; Santich, B.; Guo, H. F.; Xu, H.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
    Journal Article

    Mao, N.; Zhang, Z.; Lee, Y. S.; Choi, D.; Agudelo Rivera, A.; Li, D.; Lee, C.; Haywood, S.; Chen, X.; Chang, Q.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save